Schedule 13G ownership disclosure
APTEVO THERAPEUTICS INC
Common Stock · CUSIP: 03835L504
Event date: 2025-09-30
- Filing-level shares
- 494,341.00
- Percent of class
- 15.0%
- BANK OF AMERICA CORP /DE/
Shares: 494,341.00 · Class: 15.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000070858-25-000377
- Form type
- SCHEDULE 13G
- Filer
- Aptevo Therapeutics Inc.
- CIK
- CIK 1671584
- Filed
- Oct 06, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership